Blue Biotechnology in Slovenia
Piran (Slovenia), March 28, 2025. National 2B-BLUE Part II: Blue Biotechnology value chains in Slovenia Treatment of leukaemia, a blood disease, took a step forward in 1951 when researchers isolated the first marine-derived anticancer agent, arabinosyl cytosine*. This...
Regional opportunities meeting in Sarajevo
Sarajevo (Bosnia and Herzegovina), April 2-4, 2025. A community for innovation The 2B-BLUE project participated in the 3rd meeting of the Innovative and Sustainable Economy Community of Practice (ISE CoP) under the Interreg Euro-MED program in Sarajevo from April...
